| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |